It’s time to tailor treatments specifically to the genetic and molecular makeup of each patient and their tumor. The budding field of multi-omics is set to birth exciting, targeted therapies that provide patients more hope with fewer debilitating side effects.

We are excited to offer that new approach to care at the forthcoming Paul G. Allen Research Center at the Swedish Cancer Institute.

Grateful for the care he received the late philanthropist Paul G. Allen, co-founder of Microsoft, made a personal bequest of $20 million to Swedish.

The gift, made shortly after his death in 2018, supports the formation of the Paul G. Allen Research Center at Swedish Cancer Institute (SCI) and funds research that will change how we treat and care for patients with cancer. Learn more: https://swedishfoundation.org/PaulGAl...